This vial contains a new drug called PAC-832, which I recently invented to treat Alzheimer’s disease. It is the world’s first selective GalR1 antagonist.
I designed and synthesized PAC-832 in a chemistry lab I built in my garage. (1/16) https://t.co/J72K43yvlX
Well, unfortunately the only real test to treat AD is in a phase 3 human trial. We have animal models but the correlation to humans is, so far, very bad. Every time we’ve cured it in a mouse it hasn’t worked in people.
Well, unfortunately the only real test to treat AD is in a phase 3 human trial. We have animal models but the correlation to humans is, so far, very bad. Every time we’ve cured it in a mouse it hasn’t worked in people.